Olstein Capital Management L.P. Boosts Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Olstein Capital Management L.P. grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 26.7% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 15,200 shares of the healthcare conglomerate’s stock after buying an additional 3,200 shares during the period. UnitedHealth Group makes up 1.4% of Olstein Capital Management L.P.’s portfolio, making the stock its 29th largest holding. Olstein Capital Management L.P.’s holdings in UnitedHealth Group were worth $7,689,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Dark Forest Capital Management LP boosted its stake in UnitedHealth Group by 76.9% during the second quarter. Dark Forest Capital Management LP now owns 734 shares of the healthcare conglomerate’s stock worth $374,000 after buying an additional 319 shares during the period. Scientech Research LLC bought a new position in UnitedHealth Group during the 2nd quarter valued at about $1,071,000. Sepio Capital LP lifted its stake in UnitedHealth Group by 0.3% in the second quarter. Sepio Capital LP now owns 5,822 shares of the healthcare conglomerate’s stock worth $2,965,000 after purchasing an additional 20 shares during the last quarter. Texas Capital Bank Wealth Management Services Inc grew its stake in shares of UnitedHealth Group by 6.6% during the second quarter. Texas Capital Bank Wealth Management Services Inc now owns 16,134 shares of the healthcare conglomerate’s stock valued at $8,216,000 after buying an additional 994 shares during the last quarter. Finally, Kathmere Capital Management LLC boosted its holdings in UnitedHealth Group by 25.1% during the 2nd quarter. Kathmere Capital Management LLC now owns 4,768 shares of the healthcare conglomerate’s stock valued at $2,428,000 after acquiring an additional 958 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.33% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday. Truist Financial dropped their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Stephens increased their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Finally, UBS Group decreased their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. One analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $627.74.

UnitedHealth Group Trading Up 0.5 %

Shares of NYSE:UNH opened at $532.26 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a market capitalization of $489.83 billion, a P/E ratio of 34.34, a P/E/G ratio of 1.41 and a beta of 0.62. The business’s 50-day moving average is $541.04 and its 200 day moving average is $563.84. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period last year, the business earned $5.83 EPS. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.74 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.58%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.